Annual SG&A
$15.38 M
+$3.38 M+28.18%
31 December 2023
Summary:
Lexeo Therapeutics Common Stock annual selling, general & administrative expenses is currently $15.38 million, with the most recent change of +$3.38 million (+28.18%) on 31 December 2023. During the last 3 years, it has risen by +$14.60 million (+1853.40%). LXEO annual SG&A is now at all-time high.LXEO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$8.12 M
+$1.13 M+16.17%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock quarterly selling, general & administrative expenses is currently $8.12 million, with the most recent change of +$1.13 million (+16.17%) on 30 September 2024. Over the past year, it has increased by +$5.09 million (+168.25%). LXEO quarterly SG&A is now at all-time high.LXEO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$864.37 M
-$86.60 M-11.13%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock TTM selling, general & administrative expenses is currently -$864.37 million, with the most recent change of -$86.60 million (-11.13%) on 30 September 2024. Over the past year, it has dropped by -$876.80 million (-7055.03%). LXEO TTM SG&A is now -648.72% below its all-time high of $29.42 million, reached on 30 September 2024.LXEO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXEO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.2% | +168.3% | -7055.0% |
| 3 y3 years | +1853.4% | - | - |
| 5 y5 years | - | - | - |
LXEO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1853.4% | at high | +206.3% | -648.7% | at low |
| 5 y | 5 years | at high | +1853.4% | at high | +206.3% | -648.7% | at low |
| alltime | all time | at high | +1853.4% | at high | +206.3% | -648.7% | at low |
Lexeo Therapeutics Common Stock Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.12 M(+16.2%) | $29.42 M(+20.9%) |
| June 2024 | - | $6.99 M(-7.4%) | $24.33 M(+21.2%) |
| Mar 2024 | - | $7.55 M(+11.6%) | $20.08 M(+30.5%) |
| Dec 2023 | $15.38 M | $6.76 M(+123.5%) | $15.38 M(+23.8%) |
| Sept 2023 | - | $3.03 M(+10.5%) | $12.43 M(+3.1%) |
| June 2023 | - | $2.74 M(-4.0%) | $12.05 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $2.85 M(-25.1%) | $12.39 M(+29.9%) |
| Dec 2022 | $12.00 M(+67.3%) | $3.81 M(+43.7%) | $9.54 M(+66.5%) |
| Sept 2022 | - | $2.65 M(-14.0%) | $5.73 M(+86.0%) |
| June 2022 | - | $3.08 M | $3.08 M |
| Dec 2021 | $7.17 M(+810.9%) | - | - |
| Dec 2020 | $787.50 K | - | - |
FAQ
- What is Lexeo Therapeutics Common Stock annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock annual SG&A year-on-year change?
- What is Lexeo Therapeutics Common Stock quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock quarterly SG&A year-on-year change?
- What is Lexeo Therapeutics Common Stock TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock TTM SG&A year-on-year change?
What is Lexeo Therapeutics Common Stock annual selling, general & administrative expenses?
The current annual SG&A of LXEO is $15.38 M
What is the all time high annual SG&A for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high annual selling, general & administrative expenses is $15.38 M
What is Lexeo Therapeutics Common Stock annual SG&A year-on-year change?
Over the past year, LXEO annual selling, general & administrative expenses has changed by +$3.38 M (+28.18%)
What is Lexeo Therapeutics Common Stock quarterly selling, general & administrative expenses?
The current quarterly SG&A of LXEO is $8.12 M
What is the all time high quarterly SG&A for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high quarterly selling, general & administrative expenses is $8.12 M
What is Lexeo Therapeutics Common Stock quarterly SG&A year-on-year change?
Over the past year, LXEO quarterly selling, general & administrative expenses has changed by +$5.09 M (+168.25%)
What is Lexeo Therapeutics Common Stock TTM selling, general & administrative expenses?
The current TTM SG&A of LXEO is -$864.37 M
What is the all time high TTM SG&A for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high TTM selling, general & administrative expenses is $29.42 M
What is Lexeo Therapeutics Common Stock TTM SG&A year-on-year change?
Over the past year, LXEO TTM selling, general & administrative expenses has changed by -$876.80 M (-7055.03%)